Репозиторій Вінницького національного медичного університету імені М. І. Пирогова

The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment

Показати скорочений опис матеріалу

dc.contributor.author Konkov, D. en
dc.date.accessioned 2017-10-18T14:40:42Z
dc.date.available 2017-10-18T14:40:42Z
dc.date.issued 2014
dc.identifier.citation Konkov D. G. The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment / D. G. Konkov // Austrian Journal of Technical and Natural Sciences. - 2014. - № 1. – Р. 46-50. en
dc.identifier.issn 2310-5607
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/1094
dc.description.abstract We are estimated the effect of low-dose aspirin (75 mg/day) depending on beginning (gestational age 11-14 vs. 16-20 weeks) in women with gestational endotheliopathy, on the incidence of preeclampsia and other perinatal complications. Our investigation showed statistically significant effect of low-dose aspirin initiated in 11-14 weeks in preventing the incidence of preeclampsia and IUGR in women with gestational endotheliopathy. ru_RU
dc.language.iso en en
dc.publisher Austrian Journal of Technical and Natural Sciences en
dc.subject gestational endotheliopathy en
dc.subject low-dose aspirin en
dc.subject preeclampsia en
dc.subject prevention en
dc.title The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment en
dc.type Article en


Файли цього елементу

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу